Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Mycobacterium Infections, Nontuberculous
Clinical Trial
NCT02344004Last updated: 12/4/2025
INSM
Insmed Incorporated
